Stefan Tiefenbacher Selected Research

fibrin fragment D (D-dimer)

12/2010

Increases in quantitative D-dimer levels correlate with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Tiefenbacher Research Topics

Disease

5	Hemophilia A (Haemophilia) 02/2021 - 04/2017
2	Hemophilia B (Haemophilia B) 02/2021 - 12/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 03/2023
1	Body Weight (Weight, Body) 12/2017
1	Hemorrhage 12/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Activated Protein C Resistance (APC Resistance) 01/2017
1	Circulating Neoplastic Cells 12/2010
1	Prostatic Neoplasms (Prostate Cancer) 12/2010

Drug/Important Bio-Agent (IBA)

3	Factor VIII (Coagulation Factor VIII)IBA 11/2020 - 04/2017
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 12/2017 - 04/2017
1	apixabanIBA 03/2023
1	emicizumabIBA 02/2021
1	Indicators and Reagents (Reagents)IBA 02/2021
1	recombinant factor VIII N8IBA 09/2019
1	factor IX-PaduaIBA 12/2017
1	prothrombin complex concentrates (PPSB)IBA 12/2017
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2017
1	CoagulantsIBA 12/2017
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	oritavancinIBA 01/2017
1	Factor Xa (Coagulation Factor Xa)IBA 01/2017
1	fibrin fragment D (D-dimer)IBA 12/2010
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2010

Therapy/Procedure

2	Therapeutics 11/2020 - 12/2010
1	Injections 04/2017
1	Castration 12/2010